Navigation Links
Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis
Date:3/31/2009

een halted and inventories are almost exhausted for the only other JE vaccine licensed in the United States today."

IXIARO was developed for over 10 years under a Collaborative Research and Development Agreement (CRADA) with the Walter Reed Army Institute of Research (WRAIR). "The expert scientists at WRAIR made a significant contribution towards development of IXIARO and Intercell is very appreciative of this outstanding collaboration. The FDA approval of IXIARO is an excellent example of what can be achieved when industry and government work together towards an important common goal. Intercell looks forward to supplying this novel vaccine to the U.S. military for use in their JE immunization program," added Zettlmeissl.

"The U.S. Department of Defense (DoD) welcomes the news that IXIARO has now been approved by FDA," stated LTC(P) Wayne Hachey, Director of Preventive Medicine in the Office of the Deputy Assistant Secretary of Defense for Force Health Protection and Readiness. "The Department has been committed to protecting its Service members from this serious disease since the threat was first recognized during World War II," Hachey said. "DoD researchers developed the initial vaccine against Japanese Encephalitis (JE) and are responsible for much of our understanding regarding the effectiveness and safety of that vaccine.

"Recognizing that a replacement vaccine would be required," Hachey explained, "DoD researchers were again at the forefront of the JE vaccine development that eventually led to IXIARO. Through a decade-long successful collaboration between DoD and Intercell, we now have an effective vaccine that early indications predict both improved safety and convenience for our Service members."

IXIARO is a purified, inactivated product for active immunization against viral infections of Japanese Encephalitis. IXIARO is manufactured at Intercell's proprietary manufacturing facility in Scotl
'/>"/>

SOURCE Intercell AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Helicobacter pylori inhibits intercellular communication of cultured gastric cells
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... NY (PRWEB) February 27, 2015 In ... to the community by providing free dental care from ... has partnered with Dentistry from the Heart, and ... 11, 2015. The first 50 patients who are in ... they can’t afford, will have access to high­quality service ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Royal River Natural ... reports a new study that found adults who got the ... type 2 diabetes compared to those who got the least ... sugar levels. , The report is part of the March ... which Royal River Natural Foods publishes free each month for ...
(Date:2/27/2015)... 27, 2015 Legislation passed today ... a pharmacy provision to help prevent inappropriate prescriptions ... counter. The Protecting the Integrity of Medicare Act ... Chairman Kevin Brady (R-TX) and Ranking Member Jim ... prescription drug abuse epidemic and implement the right ...
(Date:2/27/2015)... The Dawn Greene Hospice, a 10-bed facility located on the ... Upper East Side, was officially dedicated and blessed at a ... Michael Cardinal Dolan. , Thomas J. Fahey, Jr., MD, chairman ... of the ArchCare Board of Trustees, presided over the event ... of MMW, and Christina McInerney, president and CEO of The ...
(Date:2/27/2015)... 27, 2015 Mediaplanet today announces the ... a campaign that aims to bring blood health and ... conversation. The stories in this edition go beyond the ... clinical care, hard-hitting advocacy, research and technological strides needed ... the American Cancer Society, approximately every 3 minutes ...
Breaking Medicine News(10 mins):Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 3Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2Health News:PCMA Statement on the ‘Protecting the Integrity of Medicare Act’ 2Health News:The Dawn Greene Hospice Is Officially Dedicated 2Health News:The Dawn Greene Hospice Is Officially Dedicated 3Health News:Know Your Blood: Raising Awareness through Mediaplanet’s “Blood Health” Campaign 2
... ULURU Inc. ... clinical evidence on the treatment of wounds using Altrazeal(TM) Transforming ... Silver will be presented at the annual APWCA National Clinical ... be presented in podium presentations and with posters on display ...
... Positive Impact on Lives of People with Insulin-Dependent Diabetes ... System, designed and produced by Insulet Corporation (Nasdaq: ... New Product Award(TM). The product was honored with the ... recognition of its innovative design that offers people living ...
... TRENTON, N.J., April 1 The Providence Service ... that its LogistiCare subsidiary, the nation,s largest coordinator ... of award from the New Jersey Department of ... Health Services (DMAHS), to provide basic non-emergency transportation ...
... applies only to those with particular gene mutation, , , ... colorectal cancer were modestly helped by the drug Erbitux, ... mutation, a new study reports. , , The study ... cancer that could not be surgically removed. Half ...
... are readmitted within a year, study finds , , WEDNESDAY, ... patients discharged from the hospital is readmitted within 30 ... within a year, a new study finds. , The ... problem that researchers believe could be prevented through better ...
... Physical Performance (EP2), a sport supplement firm, has partnered ... manufactures a new generation of safe and effective ingredients ... physical performance. Together, they will bring innovative new products ... goers. TORABOLIC is Indus,s first new novel ingredient that ...
Cached Medicine News:Health News:Altrazeal(TM) Clinical Evidence to be Presented at The American Professional Wound Care Association (APWCA) National Clinical Conference 2009 2Health News:Altrazeal(TM) Clinical Evidence to be Presented at The American Professional Wound Care Association (APWCA) National Clinical Conference 2009 3Health News:OmniPod(R) Insulin Management System Wins 2009 Edison Best New Product Award 2Health News:OmniPod(R) Insulin Management System Wins 2009 Edison Best New Product Award 3Health News:Providence's LogistiCare Subsidiary Receives Notice of Award for Five Year Approximately $300 Million New Jersey Statewide Non-Emergency Medical Transportation Contract 2Health News:Providence's LogistiCare Subsidiary Receives Notice of Award for Five Year Approximately $300 Million New Jersey Statewide Non-Emergency Medical Transportation Contract 3Health News:Erbitux May Help Some With Colorectal Cancer 2Health News:Erbitux May Help Some With Colorectal Cancer 3Health News:High Rate of Rehospitalizations Costing Billions 2Health News:High Rate of Rehospitalizations Costing Billions 3Health News:New Sports Supplement Company to Partner with Indus Biotech 2
(Date:2/27/2015)... 27, 2015 ... für kongestive Herzinsuffizienz (CHF) in seiner ersten ...     Die israelische ... Herzüberwachungssystem für Patienten mit kongestiver Herzinsuffizienz (CHF) ... ein Finanzierungsvorhaben über 5 Mio. USD abgeschlossen ...
(Date:2/27/2015)... -- Bionik Laboratories Corp. (OTC:DWTPD), a Delaware ... Bionik Laboratories, Inc., a Toronto ... accredited investors of units consisting of its common stock ... million. Shares of the Company,s common stock will continue ... symbol "DWTPD" until FINRA,s approval of the ticker "BNKL." ...
(Date:2/27/2015)... NEW YORK , Feb. 27, 2015 ... DESI are increasing in applications as their ... research firm Kalorama Information.  Kalorama Information says ... MS) is the most powerful tool in ... (mass spec; MS) through its traditional techniques ...
Breaking Medicine Technology:Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3
... LLC , a drug research and development company focused ... it was issued Patent 8,012,710: Methods of treating ...  The patent covers Curemark,s biomarker as applied to diagnosing ... if an individual has a likelihood to develop Parkinson,s ...
... BROOK, N.J., Sept. 8, 2011 Elusys Therapeutics, ... announced today that it has been awarded the ... for pre- and post-exposure prophylaxis (PEP) use via ... up to $68.9 million, will support multiple animal ...
Cached Medicine Technology:Curemark Issued Patent for the Diagnosis of Parkinson's Disease 2Elusys Awarded $68 Million Contract to Develop Anthim for Intramuscular Pre- and Post-Exposure Prophylaxis of Anthrax Infection 2Elusys Awarded $68 Million Contract to Develop Anthim for Intramuscular Pre- and Post-Exposure Prophylaxis of Anthrax Infection 3
An entirely new way to brighten and enhance natural eye color....
Expressions lets you change your eye color with lenses that offer incredible comfort and outstanding vision quality. Expression color lenses use a technologically advanced tinting process to produce ...
Lumenis offers you the latest non-invasive system for Intense Pulsed Light (IPL) skin treatments using proprietary broad spectrum IPL technology....
... in an upgradeable skin treatment system. ... of photo-aged skin, removes age spots ... and broken capillaries through a process ... Intense,Pulsed Light (IPLTM) treat facial vascular ...
Medicine Products: